DEAMIDATION OF SOLUBLE CD4 AT ASPARAGINE-52 RESULTS IN REDUCED BINDING-CAPACITY FOR THE HIV-1 ENVELOPE GLYCOPROTEIN GP120

被引:48
作者
TESHIMA, G [1 ]
PORTER, J [1 ]
YIM, K [1 ]
LING, V [1 ]
GUZZETTA, A [1 ]
机构
[1] GENENTECH INC, DEPT PHARMACEUT RES & DEV, SAN FRANCISCO, CA 94080 USA
关键词
D O I
10.1021/bi00230a016
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
High-performance cation-exchange chromatography of recombinant soluble CD4 (rCD4) allowed the resolution of four charge variants. This charge heterogeneity could be eliminated by neuraminidase treatment of rCD4 and therefore can be attributed to different degrees of sialylation of the carbohydrate portion of this glycoprotein. A single acidic variant was observed upon cation-exchange chromatography of neuraminidase-treated rCD4 that had been stored in liquid solution, pH 7.2, at 25-degrees-C for 6 months. This acidic variant was isolated by semipreparative cation-exchange chromatography and subjected to tryptic mapping analysis. Tryptic peptides were characterized by fast atom bombardment mass spectrometry (FABMS). The results of this analysis demonstrated that the acidic variant of neuraminidase-treated rCD4 is generated from deamidation at Asn-52. Digestion of the deamidated rCD4 with endoproteinase Asp-N confirmed Asn-52 as the primary site of deamidation. The ability of the deamidated rCD4 variant to bind gp120 was assessed by use of an ELISA-based binding assay. The binding capacity of the deamidated variant was 24% of the binding capacity of unmodified rCD4. The overall structure of the V1 domain in the deamidated variant was not markedly different from that of the native protein as probed with eight conformationally dependent anti-V1 monoclonal antibodies. Therefore, it appears that Asn-52 is directly involved in binding to gp120.
引用
收藏
页码:3916 / 3922
页数:7
相关论文
共 37 条
[1]   CONTROL OF OLIGOMERIC ENZYME THERMOSTABILITY BY PROTEIN ENGINEERING [J].
AHERN, TJ ;
CASAL, JI ;
PETSKO, GA ;
KLIBANOV, AM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (03) :675-679
[2]   THE MECHANISM OF IRREVERSIBLE ENZYME INACTIVATION AT 100-DEGREES-C [J].
AHERN, TJ ;
KLIBANOV, AM .
SCIENCE, 1985, 228 (4705) :1280-1284
[3]   IDENTIFICATION OF THE RESIDUES IN HUMAN CD4 CRITICAL FOR THE BINDING OF HIV [J].
ARTHOS, J ;
DEEN, KC ;
CHAIKIN, MA ;
FORNWALD, JA ;
SATHE, G ;
SATTENTAU, QJ ;
CLAPHAM, PR ;
WEISS, RA ;
MCDOUGAL, JS ;
PIETROPAOLO, C ;
AXEL, R ;
TRUNEH, A ;
MADDON, PJ ;
SWEET, RW .
CELL, 1989, 57 (03) :469-481
[4]   MAPPING THE CD4 BINDING-SITE FOR HUMAN-IMMUNODEFICIENCY-VIRUS BY ALANINE-SCANNING MUTAGENESIS [J].
ASHKENAZI, A ;
PRESTA, LG ;
MARSTERS, SA ;
CAMERATO, TR ;
ROSENTHAL, KA ;
FENDLY, BM ;
CAPON, DJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (18) :7150-7154
[5]  
ASWAD DW, 1984, J BIOL CHEM, V259, P714
[6]   ISOLATION OF A T-LYMPHOTROPIC RETROVIRUS FROM A PATIENT AT RISK FOR ACQUIRED IMMUNE-DEFICIENCY SYNDROME (AIDS) [J].
BARRESINOUSSI, F ;
CHERMANN, JC ;
REY, F ;
NUGEYRE, MT ;
CHAMARET, S ;
GRUEST, J ;
DAUGUET, C ;
AXLERBLIN, C ;
VEZINETBRUN, F ;
ROUZIOUX, C ;
ROZENBAUM, W ;
MONTAGNIER, L .
SCIENCE, 1983, 220 (4599) :868-871
[7]  
BODANSZKY M, 1978, INT J PEPT PROT RES, V12, P69
[8]  
BRODSKY MH, 1990, J IMMUNOL, V144, P3078
[9]  
CARR SA, 1989, J BIOL CHEM, V264, P21286
[10]  
CHAO BH, 1989, J BIOL CHEM, V264, P5812